Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review

Surgery Today ◽  
2015 ◽  
Vol 46 (9) ◽  
pp. 1045-1052 ◽  
Author(s):  
Yusuke Watanabe ◽  
Kazuyoshi Nishihara ◽  
Yusuke Niina ◽  
Yuji Abe ◽  
Takao Amaike ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Retrospective Review ◽  
Management Strategy ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Mucinous Neoplasm ◽  
International Consensus Guidelines

scholarly journals Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm?

2021 ◽  
Vol 10 (9) ◽  
pp. 1818
Author(s):  
Tomohiro Yamazaki ◽  
Mamoru Takenaka ◽  
Shunsuke Omoto ◽  
Tomoe Yoshikawa ◽  
Rei Ishikawa ◽  
...  
Keyword(s):  
Intraductal Papillary Mucinous Neoplasm ◽  
Predictive Value ◽  
Diagnostic Value ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Mucinous Neoplasm ◽  
Appropriate Treatment ◽  
Contrast Enhanced ◽  
Diagnostic Values ◽  
International Consensus Guidelines

This study aimed to investigate whether the incorporation of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) into the international consensus guidelines (ICG) for the management of intraductal papillary mucinous neoplasm (IPMN) could improve its malignancy diagnostic value. In this single-center retrospective study, 109 patients diagnosed with IPMN who underwent preoperative CH-EUS between March 2010 and December 2018 were enrolled. We analyzed each malignancy diagnostic value (sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV)) by replacing fundamental B-mode EUS with CH-EUS as the recommended test for patients with worrisome features (WF) (the CH-EUS incorporation ICG) and comparing the results to those obtained using the 2017 ICG. The malignancy diagnostic values as per the 2017 ICG were 78.9%, 42.3%, 60.0%, and 64.7% for Se, Sp, PPV, and NPV, respectively. The CH-EUS incorporation ICG plan improved the malignancy diagnostic values (Se 78.9%/Sp, 53.8%/PPV, 65.2%/NPV 70.0%). CH-EUS may be useful in determining the appropriate treatment strategies for IPMN.

Validation of international consensus guidelines for intraductal papillary mucinous neoplasm of pancreas - a monocenter retrospective study

Pancreatology ◽  
2017 ◽  
Vol 17 (3) ◽  
pp. S120
Author(s):  
Lenika Calavrezos ◽  
Sarah Flechsenhar ◽  
Carsten Jäger ◽  
Ihsan Ekin Demir ◽  
Christoph Schlag ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Intraductal Papillary Mucinous Neoplasm ◽  
Consensus Guidelines ◽  
International Consensus ◽  
Mucinous Neoplasm ◽  
International Consensus Guidelines
Sign in / Sign up

Export Citation Format

Share Document